Symbol="IFRX"
AssetType="Common Stock"
Name="InflaRx N.V."
Description="InflaRx NV, a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company is headquartered in Jena, Germany."
CIK="1708688"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="WINZERLAER STR. 2, JENA, DE"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="240833000"
EBITDA="-55712016"
PERatio="None"
PEGRatio="None"
BookValue="1.755"
DividendPerShare="0"
DividendYield="0"
EPS="-0.66"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.346"
ReturnOnEquityTTM="-0.306"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.66"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="11.4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.973"
EVToRevenue="-"
EVToEBITDA="0.0439"
Beta="0.987"
num_52WeekHigh="7.25"
num_52WeekLow="1.57"
num_50DayMovingAverage="4.275"
num_200DayMovingAverage="3.171"
SharesOutstanding="58883000"
DividendDate="None"
ExDividendDate="None"
symbol="IFRX"
open="4.05"
high="4.12"
low="4.01"
price="4.09"
volume="94531.00"
latest_trading_day="2023-07-28"
previous_close="4.07"
change="0.02"
change_percent="0.4914%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="39"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="61"
Volume_recent_avg="1601391"
Change_recent_avg="0.01"
Delta_recent_avg="0.31"
Variance_recent_avg="0.15"
Change_ratio_recent_avg="0.13"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="61"
Aroon_momentum_negative="39"
image_negative_thumbnail_id_1="126"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0050.jpeg"
image_negative_thumbnail_id_2="111"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0065.jpeg"
image_neutral_thumbnail_id_1="568"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0031.jpeg"
image_neutral_thumbnail_id_2="587"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0012.jpeg"
image_positive_thumbnail_id_1="643"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0065.jpeg"
image_positive_thumbnail_id_2="647"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0061.jpeg"
image_professor_thumbnail_id_1="1195"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
